The University of Pittsburgh was ranked seventh in the nation for National Institutes of Health (NIH) research funding in 2025, receiving $669.7 million, according to new data from the Blue Ridge Institute for Medical Research. Including an additional $16.1 million allocated for OB-GYN research, Pitt’s total NIH-funded research reached $685.8 million for the federal fiscal year ending September 30.
All six of Pitt’s health sciences schools were recognized among the top 20 nationally within their respective categories. The School of Health and Rehabilitation Sciences notably advanced seven positions to rank sixth with $9.8 million in funding, representing a 96% increase from the previous year. The School of Medicine secured eighth place nationally with $555.4 million in NIH support. Other rankings include the School of Public Health at tenth, Dental Medicine at eleventh with a 30% increase to $7.5 million, Nursing at sixteenth, and Pharmacy at nineteenth.
Pitt also achieved several top-10 placements across specific research disciplines: first in physical medicine and psychiatry; second in microbiology and pharmacology; third in otolaryngology; fourth in anesthesiology; fifth in neurosciences; sixth in internal medicine and surgery; seventh in dermatology; ninth in anatomy/cell biology; and tenth in radiology.
“In a year in which the landscape shifted dramatically for federal funding of scientific research, I am very proud that all six of our health sciences schools were among the top 20, which is a real testament to the excellence and productivity of our researchers,” said Anantha Shekhar, senior vice chancellor for the health sciences and John and Gertrude Petersen Dean of the School of Medicine.
